Antimicrobial Agents Practice Questions

Q: All of the following drugs can be used for the management of malaria due to chloroquine-resistant vivax except?

Fluoroquinolones. **Explanation:** The management of chloroquine-resistant *Plasmodium vivax* (CRPV) has become a clinical challenge in certain endemic regions (e.g., Indonesia, parts of India). According to WHO and National Guidelines, the treatment strategy for CRPV mirrors that of *P. falciparum*. **Why Fluoroquinolones are the Correct Answer:** While some fluoroquinolones (like Ciprofloxacin or Levofloxacin) exhibit weak anti-plasmodial activity *in vitro*, they are **not clinically recommended** or effective for the management of malaria. They lack the potency required to clear parasites effectively and are never used as standard therapy for any form of malaria. **Analysis of Other Options:** * **Artesunate (Option C):** ACT (Artemisinin-based Combination Therapy) is the current **first-line treatment** for chloroquine-resistant malaria (both *falciparum* and *vivax*). * **Quinine (Option A):** Historically the mainstay for resistant malaria, it remains an effective alternative, especially in severe cases or when ACTs are unavailable. * **Doxycycline (Option B):** It is a slow-acting blood schizonticide used as an **adjunct** to Quinine to ensure complete parasite clearance and prevent recrudescence. **High-Yield Clinical Pearls for NEET-PG:** 1. **First-line for CRPV:** ACT (e.g., Artesunate + Lumefantrine) is preferred. 2. **Radical Cure:** Regardless of the drug used for blood schizonts, **Primaquine** (for 14 days) must be added to treat hypnozoites in the liver to prevent relapse in *P. vivax*. 3. **Tafenoquine:** A newer single-dose alternative to Primaquine for radical cure (requires G6PD screening). 4. **Mechanism of Chloroquine Resistance:** Primarily due to mutations in the **PvCRT-o** gene (ortholog to PfCRT) or **PvMDR1** gene.

Q: Which among the following drugs is safest in a patient allergic to penicillin?

Aztreonam. **Explanation:** The correct answer is **Aztreonam**. **Why Aztreonam is the correct choice:** Aztreonam is a **Monobactam**. Unlike other beta-lactams, it possesses a unique monocyclic beta-lactam ring that does not share the common bicyclic nucleus found in penicillins and cephalosporins. Consequently, there is **no cross-reactivity** between Aztreonam and other beta-lactams (except for Ceftazidime, with which it shares a side chain). It is considered the drug of choice when a patient with a documented severe penicillin allergy requires coverage for Gram-negative aerobic bacteria. **Why the other options are incorrect:** * **Cephalexin (1st Gen Cephalosporin) & Cefepime (4th Gen Cephalosporin):** Cephalosporins share a similar structural nucleus with penicillins. In patients with a history of Type-1 hypersensitivity (anaphylaxis) to penicillin, there is a significant risk (approx. 1-10%) of cross-reactivity. * **Imipenem (Carbapenem):** Carbapenems also share a bicyclic ring structure. While the cross-reactivity rate is lower than previously thought (around 1%), it is still significantly higher than that of Aztreonam, making it less "safe" in the context of this question. **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum of Aztreonam:** It is active **only against Gram-negative aerobes** (e.g., *Pseudomonas*, *E. coli*). It has no activity against Gram-positives or anaerobes ("Aztreonam is a Lone Ranger against Gram-negatives"). * **Exception to the Rule:** Aztreonam should be avoided in patients allergic to **Ceftazidime** due to identical side chains. * **Safe Alternatives:** For penicillin-allergic patients, Macrolides (Erythromycin) or Clindamycin are often used for Gram-positive coverage, while Aztreonam is used for Gram-negative coverage.

Q: What is the most common side effect of miltefosine?

Vomiting and diarrhea. **Explanation:** **Miltefosine** is a landmark drug in the treatment of Leishmaniasis as it is the **first and only oral agent** effective against Visceral Leishmaniasis (Kala-azar). It is an alkylphosphocholine analogue that acts by interfering with cell membrane signaling and inducing apoptosis in the *Leishmania* parasite. 1. **Why Option A is correct:** The most frequent adverse effects of miltefosine are **gastrointestinal (GI) disturbances**. Approximately 40–60% of patients experience **vomiting and diarrhea**. These symptoms are usually dose-dependent, occur early in the treatment course, and are generally transient or manageable with antiemetics and hydration. 2. **Why other options are incorrect:** * **Dermatitis (B):** While skin rashes can occur, they are rare and not the primary side effect. * **Hepatotoxicity (C):** Transient elevations in liver enzymes (ALT/AST) can occur, but this is significantly less common than GI distress. * **Nephrotoxicity (D):** Miltefosine can cause a transient rise in creatinine levels, but it is not primarily known for nephrotoxicity (unlike Amphotericin B, another drug used for Leishmaniasis). **High-Yield Clinical Pearls for NEET-PG:** * **Teratogenicity:** Miltefosine is strictly **contraindicated in pregnancy** due to its potent teratogenic effects. Female patients of reproductive age must use effective contraception during and for **5 months after** treatment (due to the drug's long half-life). * **Drug of Choice:** It is a primary treatment for both Visceral and Post-Kala-azar Dermal Leishmaniasis (PKDL). * **Mechanism:** It inhibits **phospholipase C** and protein kinase C, disrupting the parasite's lipid metabolism.

Q: Which drug is used for prophylaxis against Haemophilus influenzae infection?

Rifampicin. **Explanation:** **Rifampicin** is the drug of choice for the prophylaxis of *Haemophilus influenzae* type b (Hib) infection. The primary goal of prophylaxis is to eliminate the nasopharyngeal carriage of the bacteria, thereby preventing the spread to susceptible individuals and reducing the risk of invasive disease (like meningitis or epiglottitis). Rifampicin is highly effective because it achieves high concentrations in respiratory secretions, effectively eradicating the carrier state. **Analysis of Options:** * **Rifampicin (Correct):** It is administered to all household contacts (if there is at least one unvaccinated child <4 years) to prevent secondary cases. The standard adult dose is 600 mg once daily for 4 days. * **Doxycycline:** While a broad-spectrum tetracycline, it is not used for Hib prophylaxis. It is more commonly used for prophylaxis in conditions like Malaria or Leptospirosis. * **Erythromycin:** This macrolide is the drug of choice for prophylaxis against *Bordetella pertussis* (Whooping cough) and *Corynebacterium diphtheriae*, but it is ineffective for eradicating the *H. influenzae* carrier state. **High-Yield Clinical Pearls for NEET-PG:** * **Meningococcal Prophylaxis:** Rifampicin is also used for prophylaxis against *Neisseria meningitidis* (Dose: 600 mg BID for 2 days). * **Mechanism of Action:** Rifampicin inhibits bacterial **DNA-dependent RNA polymerase**. * **Side Effect:** Warn patients about the **orange-red discoloration** of urine, sweat, and tears. * **Contraindication:** It is a potent **enzyme inducer** (CYP450), leading to numerous drug interactions (e.g., reducing the efficacy of oral contraceptives).

Q: Which of the following is an approved oral therapy for Leishmaniasis?

Miltefosine. **Explanation:** **Miltefosine** is the correct answer as it is currently the **only approved oral drug** for the treatment of both Visceral Leishmaniasis (Kala-azar) and Cutaneous Leishmaniasis [2]. Originally developed as an anticancer agent, it acts by inhibiting protein kinase C and phospholipase B, leading to apoptosis-like cell death in the *Leishmania* parasite [2]. Its oral bioavailability makes it a landmark therapy, especially in resource-limited settings where parenteral administration is difficult. **Analysis of Incorrect Options:** * **Sodium Stibogluconate (Option A):** A pentavalent antimonial that was the first-line treatment for decades [3]. It must be administered **intravenously or intramuscularly**. Its use has declined significantly due to widespread resistance (especially in Bihar, India) and cardiotoxicity [3]. * **Pentamidine (Option B):** An aromatic diamidine used as a second-line agent. It is administered **parenterally** [4] and is associated with significant toxicities, including insulin-dependent diabetes mellitus and hypotension. * **Amphotericin B (Option D):** A polyene antibiotic that is highly effective against Leishmania [1]. While Liposomal Amphotericin B is the current **drug of choice** for Kala-azar due to high cure rates, it must be administered via **slow intravenous infusion** [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Teratogenicity:** Miltefosine is strictly contraindicated in pregnancy [2]. Women of childbearing age must use effective contraception during and for 3-5 months after treatment. * **Drug of Choice:** Liposomal Amphotericin B (L-AmB) is the preferred treatment in India (single dose 10mg/kg) [3]. * **Post-Kala-azar Dermal Leishmaniasis (PKDL):** Miltefosine is also used in the management of PKDL, typically requiring a longer duration of therapy (12 weeks).

Q: Non-oliguric acute renal failure is caused by which of the following drugs?

Aminoglycoside. **Explanation:** **1. Why Aminoglycosides are correct:** Aminoglycosides (e.g., Gentamicin, Amikacin) are notorious for causing **dose-dependent nephrotoxicity**. They are filtered by the glomerulus and actively reabsorbed by the proximal convoluted tubule (PCT) cells, where they accumulate in lysosomes. This leads to tubular necrosis. Characteristically, this presents as **non-oliguric acute renal failure (ARF)**. In this condition, the glomerular filtration rate (GFR) drops, but the patient continues to produce a normal or even high volume of urine because the damaged tubules lose their ability to concentrate urine and reabsorb water. **2. Why the other options are incorrect:** * **Penicillin & Ampicillin:** While Penicillins can cause renal issues, they typically manifest as **Acute Interstitial Nephritis (AIN)**—an immune-mediated hypersensitivity reaction. This is characterized by fever, rash, eosinophilia, and eosinophiluria, rather than direct toxic non-oliguric tubular necrosis. * **Erythromycin:** This macrolide is primarily metabolized by the liver and excreted in bile. It is not associated with significant nephrotoxicity; its primary side effects are GI upset and cholestatic jaundice. **3. Clinical Pearls for NEET-PG:** * **Mechanism:** Aminoglycoside toxicity is due to accumulation in the renal cortex (PCT). * **Reversibility:** The damage is usually reversible if the drug is discontinued early. * **Monitoring:** Therapeutic Drug Monitoring (TDM) and monitoring serum creatinine are essential. * **Other causes of Non-oliguric ARF:** Amphotericin B, Cisplatin, and Methoxyflurane. * **Ototoxicity:** Remember that Aminoglycosides also cause irreversible ototoxicity (vestibular/cochlear damage).

Q: Which of the following is NOT true about protease inhibitors?

Saquinavir causes maximum induction of CYP3A4.. **Explanation:** The correct answer is **D**. This statement is incorrect because Protease Inhibitors (PIs) are primarily **inhibitors** of the CYP3A4 enzyme, not inducers. Among the PIs, **Ritonavir** is the most potent inhibitor of CYP3A4, a property utilized in "Ritonavir boosting" to increase the plasma concentrations of other PIs (like Lopinavir). Saquinavir, in fact, has the lowest inhibitory potential among the group and does not cause significant induction. **Analysis of other options:** * **Option A:** PIs are indeed substrates for **P-glycoprotein (P-gp)**, an efflux transporter encoded by the **MDR1 gene**. This transporter limits their absorption in the gut and penetration into the CNS, contributing to "sanctuary sites" where the virus can persist. * **Option B:** PIs undergo extensive **hepatic oxidative metabolism**, primarily via the CYP3A4 isoenzyme. This is why their bioavailability is highly variable and dependent on liver function. * **Option C:** Because PIs (especially Ritonavir) strongly inhibit CYP3A4, they significantly interfere with the metabolism of co-administered drugs (e.g., statins, benzodiazepines, and rifampin), leading to potential toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Ritonavir:** Used as a "pharmacokinetic enhancer" (booster) rather than for its own antiviral effect at low doses. * **Metabolic Side Effects:** PIs are classically associated with **Lipodystrophy** (buffalo hump), hyperlipidemia, and insulin resistance (hyperglycemia). * **Atazanavir:** Known for causing unconjugated hyperbilirubinemia (jaundice) but is preferred because it has the least impact on lipid profiles. * **Tipranavir:** Associated with a risk of intracranial hemorrhage.

Q: A young male presents with meningococcal meningitis and allergy to penicillin. Which is the most suitable drug?

Chloramphenicol. **Explanation:** The management of meningococcal meningitis in a patient with a **penicillin allergy** requires an antibiotic that achieves high cerebrospinal fluid (CSF) concentrations and covers *Neisseria meningitidis*. **Why Chloramphenicol is correct:** Chloramphenicol is highly lipid-soluble, allowing it to cross the blood-brain barrier effectively, reaching therapeutic levels in the CSF even without active inflammation. It is primarily bacteriostatic but acts **bactericidal** specifically against the three most common causes of bacterial meningitis: *N. meningitidis*, *S. pneumoniae*, and *H. influenzae*. Due to its distinct chemical structure, it does not cross-react with penicillins, making it the classic alternative for meningococcal meningitis in allergic patients. **Why the other options are incorrect:** * **Meropenem:** While it has excellent CNS penetration, it is a Carbapenem (a Beta-lactam). There is a risk of cross-reactivity in patients with severe penicillin allergies (Type I hypersensitivity). * **Ciprofloxacin:** While used for **prophylaxis** of meningococcal meningitis in close contacts, it is not the drug of choice for the treatment of active meningitis due to inferior clinical efficacy compared to standard agents. * **Teicoplanin:** This is a glycopeptide (similar to Vancomycin) that targets Gram-positive organisms (like MRSA). It has no activity against *N. meningitidis*, which is a Gram-negative diplococcus. **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** For Meningococcal meningitis, the DOC is **Ceftriaxone** or Penicillin G. * **Prophylaxis:** The DOC for prophylaxis of meningococcal meningitis is **Rifampicin** (Ciprofloxacin or Ceftriaxone are alternatives). * **Toxicity:** Remember Chloramphenicol is associated with **Bone Marrow Suppression** (dose-dependent) and **Aplastic Anemia** (idiosyncratic), as well as **Gray Baby Syndrome** in neonates.

Q: Which of the following drugs is known to cause neuropsychiatric side effects?

Cycloserine. **Explanation:** **Cycloserine** is a second-line antitubercular drug that acts by inhibiting D-alanyl-D-alanine synthetase and alanine racemase, thereby disrupting bacterial cell wall synthesis. It is highly lipid-soluble and readily crosses the blood-brain barrier. Its structural similarity to the amino acid D-alanine allows it to act as a partial agonist at the **NMDA (N-methyl-D-aspartate) receptors** in the CNS. This interaction leads to significant **neuropsychiatric side effects**, ranging from headache and somnolence to severe psychosis ("Cycloserine psychosis"), tremors, and convulsions. To mitigate these effects, it is often co-administered with Pyridoxine (Vitamin B6). **Analysis of Incorrect Options:** * **Ethosuximide:** An antiepileptic used for absence seizures. While it can cause drowsiness or GI upset, it is not primarily known for inducing the acute psychiatric disturbances associated with cycloserine. * **Pyrazinamide:** A first-line ATT drug primarily known for **hepatotoxicity** and **hyperuricemia** (leading to gout) due to inhibition of uric acid excretion. * **Rifampicin:** A bactericidal ATT drug known for causing **orange-colored secretions** (urine, sweat, tears) and being a potent **microsomal enzyme inducer**. **NEET-PG High-Yield Pearls:** * **Cycloserine Contraindication:** Strictly contraindicated in patients with a history of epilepsy or mental illness. * **Mnemonic:** Remember **"Psych-oserine"** to link Cycloserine with psychiatric side effects. * **Other drugs causing Psychosis:** Isoniazid (INH), Fluoroquinolones, and Corticosteroids.

Question 1

All of the following drugs can be used for the management of malaria due to chloroquine-resistant vivax except?

Accepted Answer

Fluoroquinolones

Answer

Quinine

Answer

Doxycycline

Answer

Artesunate

Question 2

The development of resistance to conventional treatment has led WHO to recommend the use of combination therapies containing artemisinin derivatives (artemisinin-based combination therapies or ACTs). Which of the following combination therapies is NOT recommended if such resistance is suspected?

Accepted Answer

Artesunate plus quinine

Answer

Artemether plus lumefantrine

Answer

Artesunate plus pyrimethamine-sulfadoxine

Answer

Artesunate plus mefloquine

Question 3

Which among the following drugs is safest in a patient allergic to penicillin?

Accepted Answer

Aztreonam

Answer

Cephalexin

Answer

Imipenem

Answer

Cefepime

Question 4

What is the most common side effect of miltefosine?

Accepted Answer

Vomiting and diarrhea

Answer

Dermatitis

Answer

Hepatotoxicity

Answer

Nephrotoxicity

Question 5

Which drug is used for prophylaxis against Haemophilus influenzae infection?

Accepted Answer

Rifampicin

Answer

Doxycycline

Answer

Erythromycin

Answer

None of the above

Question 6

Which of the following is an approved oral therapy for Leishmaniasis?

Accepted Answer

Miltefosine

Answer

Sodium Stibogluconate

Answer

Pentamidine

Answer

Amphotericin B

Question 7

Non-oliguric acute renal failure is caused by which of the following drugs?

Accepted Answer

Aminoglycoside

Answer

Penicillin

Answer

Erythromycin

Answer

Ampicillin

Question 8

Which of the following is NOT true about protease inhibitors?

Accepted Answer

Saquinavir causes maximum induction of CYP3A4.

Answer

They act as a substrate for P-glycoprotein and their action is mediated by the MDR1 gene.

Answer

They undergo hepatic oxidative metabolism.

Answer

Protease inhibitors interfere with the metabolism of several drugs.

Question 9

A young male presents with meningococcal meningitis and allergy to penicillin. Which is the most suitable drug?

Accepted Answer

Chloramphenicol

Answer

Meropenem

Answer

Ciprofloxacin

Answer

Teicoplanin

Question 10

Which of the following drugs is known to cause neuropsychiatric side effects?

Accepted Answer

Cycloserine

Answer

Ethosuximide

Answer

Pyrazinamide

Answer

Rifampicin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?